Yubo International Biotech
(OTC) YBGJ
Yubo International Biotech Financials at a Glance
Market Cap
$1.70M
Revenue (TTM)
$134.39K
Net Income (TTM)
$1.08M
EPS (TTM)
$-0.01
P/E Ratio
-1.11
Dividend
$0.00
Beta (Volatility)
-0.29 (Low)
Dividend
$0.00
Beta (Volatility)
-0.29 (Low)
Price
$0.01
Volume
10,000
Open
$0.01
Price
$0.01
Volume
10,000
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.18
Dividend
$0.00
Beta (Volatility)
-0.29 (Low)
Price
$0.01
Volume
10,000
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.18
YBGJ News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Yubo International Biotech
Industry
Biotechnology
Sector
Health CareEmployees
14
CEO
Wang Yang, MBA
Website
www.yubogroup.comHeadquarters
Beijing, CN
YBGJ Financials
Key Financial Metrics (TTM)
Gross Margin
6%
Operating Margin
-9%
Net Income Margin
-8%
Return on Equity
0%
Return on Capital
61%
Return on Assets
-1%
Earnings Yield
-90.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.70M
Shares Outstanding
170.42M
Volume
10.00K
Short Interest
0.00%
Avg. Volume
3.84K
Financials (TTM)
Gross Profit
$8.16K
Operating Income
$1.19M
EBITDA
$1.02M
Operating Cash Flow
$842.80K
Capital Expenditure
$0.00
Free Cash Flow
$842.80K
Cash & ST Invst.
$8.06K
Total Debt
$78.78K
Yubo International Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$134.39K
+746716.7%
Gross Profit
$141.52K
+1088707.7%
Gross Margin
1.05%
N/A
Market Cap
$1.70M
N/A
Market Cap/Employee
$94.68K
N/A
Employees
18
N/A
Net Income
$136.51K
+52.9%
EBITDA
$126.82K
+59.2%
Quarterly Fundamentals
Net Cash
$70.72K
+85.0%
Accounts Receivable
$138.04K
-68.8%
Inventory
$24.03K
-35.0%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$78.78K
-78.6%
Return on Assets
-1.27%
N/A
Return on Invested Capital
61.09%
N/A
Free Cash Flow
$279.77K
+130.0%
Operating Cash Flow
$279.77K
+130.0%